SCHEMBL19049385

SCHEMBL19049385

COc1ccc(C2CN(C(C)=O)CCO2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE2A O00408 1/20 0.44
POLB P06746 2/20 0.44
FKBP1A P62942 2/20 0.44
AKR1C3 P42330 1/20 0.44
BLM P54132 1/20 0.44
MMP1 P03956 1/20 0.44
MMP3 P08254 1/20 0.44
MMP7 P09237 1/20 0.44
MMP9 P14780 1/20 0.44
MMP13 P45452 1/20 0.44
ALDH1A1 P00352 3/20 0.43
CYP1A2 P05177 2/20 0.43
CYP3A4 P08684 2/20 0.43
CYP2D6 P10635 2/20 0.43
KDM4E B2RXH2 1/20 0.43
MAPT P10636 1/20 0.43
CYP2C9 P11712 1/20 0.43
PKM P14618 1/20 0.43
HPGD P15428 1/20 0.43
CYP2C19 P33261 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5028952 0.86 ALDH1A1 (0.44) PDE2APOLBFKBP1AALDH1A1CYP2D6
SCHEMBL19002801 0.85 MMP1 (0.45) PDE2APOLBFKBP1AAKR1C3BLM
SCHEMBL19002794 0.85 DRD3 (0.47) PDE2APOLBFKBP1AALDH1A1HPGD
SCHEMBL19049374 0.84 L3MBTL1 (0.48) PDE2AALDH1A1CYP2D6KDM4EHPGD
SCHEMBL15864467 0.83 USP30 (0.41) PDE2AAKR1C3DRD3PDE4B
SCHEMBL19049375 0.83 MEN1 (0.46) PDE2ACYP1A2CYP2D6GSK3B
SCHEMBL17095010 0.83 CASP6 (0.45) PDE2ADRD3PDE4B
SCHEMBL12468940 0.83 MAOB (0.44) AKR1C3ALDH1A1DRD3
SCHEMBL25453440 0.82 USP30 (0.54) PDE2APOLBCYP1A2CYP2D6DRD3
SCHEMBL19049384 0.82 USP30 (0.54) PDE2APOLBCYP1A2CYP2D6DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3642209-B1 COMPOUNDS THAT INTERACT WITH THE RAS SUPERFAMILY FOR THE TREATMENT OF CANCERS, INFLAMMATORY DISEASES, RASOPATHIES, AND FIBROTIC DISEASE SHY Therapeutics LLC (US) 2023-11-29 EP disclosed
EP-3394056-B1 COMPOUNDS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASE SHY Therapeutics LLC (US) 2021-04-14 EP disclosed
WO-2017112777-A1 COMPOUNDS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASE SHY Therapeutics LLC (US) 2017-06-29 WO disclosed